Biotech Showcase
Join us virtually
January 10–12, 2022 &January 17–19, 2022

Elizabeth Kelly
Fund Manager at Asia Innovation Ventures

Profile

Elizabeth joined Pappas Capital in 2021 to manage the firm’s new specialized fund, Asia Innovation Ventures. Prior to joining Pappas, she consulted for early-stage life sciences and technology companies, coaching, and advising management teams on fundraising, growth, competitive and business development strategies. Elizabeth was previously part of the investment team at Echo Health Ventures, and its predecessor, Mosaic Health Solutions, both subsidiaries of Blue Cross NC, and structured the merger of Mosaic and Cambia Health Solutions’ investment teams that resulted in the launch of Echo in 2016. In addition, she took on an interim role advising Blue Cross NC on corporate development initiatives, contributing financial and operational expertise to set-up a payer-provider joint venture. Prior to Mosaic, Elizabeth had a variety of cross-functional responsibilities at Chimerix (NASDAQ: CMRX), a biopharmaceutical company developing antiviral therapies. In addition to playing a leadership role in the company’s 2013 IPO, she spearheaded activities in corporate development, finance, marketing, IR, and PR. She began her career as an Analyst at Pappas Ventures, where she managed the deal flow process and supported fundraising efforts for a $102 million new venture fund.

Education:

University of North Carolina at Chapel Hill – Kenan-Flagler Business School (MBA in Finance, Entrepreneurship)
University of North Carolina at Chapel Hill (BA in Management, Spanish)

Agenda Sessions

  • It’s a small world after all: the impact of global economies and global health needs to the biotech sector in China

    On Demand